Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV

NCT03837756 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Saline
DRUG: Lefitolimod
DRUG: 3BNC117 and 10-1074

Sponsor

University of Aarhus

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]